Amy S. Chappell - Concepedia

Author

Amy S. Chappell

Also Known As

A CHAPPELL, A. Chappell, A. S. Chappell, A.S. Chappell, AMY S. CHAPPELL, Amy Chappell, Amy S Chappell, Amy S. Chappell, Amy S. Chappell, Chappell, A.

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Indiana University School of Medicine University of Washington Indiana University – Purdue University Indianapolis Swedish Medical Center

About

Amy S. Chappell is an author at Eli Lilly (United States) specializing in medicine, health sciences, and pain medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.5K
2	Health Sciences	13	13	1.4K
3	Applied Physiology	1	1	130
4	Athletic Training	1	1	24
5	Diabetes	1	1	15

Amy S. Chappell

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆ Jon I. Russell, Philip J. Mease, Timothy R. Smith, Pain Pain TherapyPain MedicinePsychotropic MedicationDuloxetine 60Pharmacotherapy	2008	369
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial Amy S. Chappell, Melissa J. Ossanna, Hong Liu‐Seifert, Pain Pain TherapyPain DisordersPain MedicineNeuropathic PainOsteoarthritis Knee Pain	2009	297
The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders John T. Farrar, Yili Pritchett, Michael J. Robinson, Journal of Pain Numeric Rating ScalePain TherapyPain SyndromePain DisordersHealth Sciences	2009	248
A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee Amy S. Chappell, D. Desaiah, Hong Liu‐Seifert, Pain Practice	2010	220
Efficacy and Safety of Duloxetine in Patients With Chronic Low Back Pain Vladimir Skljarevski, D. Desaiah, Hong Liu‐Seifert, Spine	2010	182
A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain Vladimir Skljarevski, Melissa J. Ossanna, Hong Liu‐Seifert, European Journal of Neurology	2009	162
Estimation of minimum clinically important difference for pain in fibromyalgia Philip J. Mease, Michael Spaeth, Daniel J. Clauw, Arthritis Care & Research	2011	152
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis Robert M. Pascuzzi, Jeremy M. Shefner, Amy S. Chappell, Amyotrophic Lateral Sclerosis Neurological DisorderExercise RehabilitationKinesiologyChronic Musculoskeletal ConditionClinical Trials	2009	130
AMPA/Kainate Antagonist LY293558 Reduces Capsaicin-evoked Hyperalgesia but Not Pain in Normal Skin in Humans Christine N. Sang, Meredith P. Hostetter, Richard H. Gracely, Anesthesiology	1998	130
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia Amy S. Chappell International Journal of General Medicine	2008	99

Page 1